‘Pharma Bro’ Martin Shkreli Released From Prison Early for Halfway House

Fourth EstateMartin Shkreli | via Social Media

Former drug firm executive Martin Shkreli, nicknamed “Pharma Bro,” has been released early from prison to a halfway house on May 18. “We can confirm Martin Shkreli transferred on May 18, 2022, from the Federal Correctional Institution Allenwood Low to …

Read more

South African COVID Vaccine Factory Still Has no Orders

Marc AndersonAspen Holdings Head Office, Durban, South Africa - Marc Anderson

The first African factory licensed to produce COVID vaccines may stop production within weeks because the facility has not received any orders.  Last year, Aspen Pharmacare signed a deal with Johnson and Johnson to produce COVID vaccines at the South …

Read more

More Research Needed for Pfizer’s Paxlovid for long COVID

Fourth EstatePaxlovid - Kches16414

According to U.S. experts, additional cases of individuals with protracted COVID who benefited from Pfizer Inc’s oral antiviral therapy Paxlovid provide new impetus for clinical studies to evaluate the medicine for the debilitating ailment. Researchers from the University of California, …

Read more

US Procures 20 Million Doses of Antiviral COVID-19 Pill

Fourth EstatePaxlovid blister pack, partially opened to reveal one Ritonavir tablet and two Nirmatrelvir tablets.

The Biden administration secured the procurement of 20 million treatment courses of Paxlovid, Pfizer’s antiviral Covid-19 tablet. Paxlovid is a five-day antiviral treatment that combines a novel antiviral medicine called nirmatrelvir with an older one called ritonavir, and is taken …

Read more

WHO Endorses Pfizer COVID-19 Pill

Fourth EstatePaxlovid—a combination of nirmatrelvir, which inhibits coronavirus replication, and ritonavir, an HIV inhibitor

Experts from the World Health Organization (WHO) endorsed Pfizer’s Paxlovid—a combination of nirmatrelvir, which inhibits coronavirus replication, and ritonavir, an HIV inhibitor that slows the liver’s breakdown of nirmatrelvir—for COVID-19 patients without severe disease who are at high risk of …

Read more

Novavax COVID-19 Vaccine and Oral Drugs Approved for Use in Australia

The Australian drug regulator Therapeutic Goods Administration (TGA) has approved the Novavax vaccine, as well as two oral treatments for vulnerable patients with COVID-19. Federal Health Minister Greg Hunt confirmed the news on Thursday, adding that Australia has ordered 51 …

Read more

Sinovac Found to be Ineffective Against Omicron

Hong Kong researchers found that Sinovac Biotech, one of the most widely used vaccines worldwide, does not provide sufficient antibodies to neutralize the Omicron variant. A statement from a team of researchers at the University of Hong Kong on Tuesday …

Read more

Moderna to Mass Produce mRNA Vaccines in Australia

US drugmaker Moderna has agreed to set up one of its biggest manufacturing facilities in Australia. Michael Azrak, head of Moderna in Australia, said he was proud Moderna would have an Australian manufacturing presence. “We’re ready to pitch tent in …

Read more

Germany Recommends Pfizer COVID Vaccine for Under-30s as it Records High Daily New Cases

Germany’s vaccine advisory committee has recommended people under the age of 30 should have only received the Biontech/Pfizer (PEF.N) COVID-19 vaccine. It has been recommended as it causes fewer heart inflammations in younger people than the Moderna (MRNA.O) shot, according …

Read more

UK Authorizes First Antiviral Pill to Treat COVID-19

The United Kingdom medicines regulator has approved on Nov. 4 the first pill to treat COVID-19 in adults at risk of severe illness. The Medicines and Healthcare products Regulatory Agency (MHRA) announced that the oral antiviral pill molnupiravir is safe …

Read more